Table 1 Detailed information on cancer types involved in this study
From: Conditional transcriptional relationships may serve as cancer prognostic markers
Cancer type (abbreviated) | Cancer type (full name) | Sample size in paired comparison | Sample size in survival analysis | Percentage of censored samples (%) |
|---|---|---|---|---|
BRCA | Breast invasive carcinoma | 112 | 980 | 89.1 |
COAD | Colon adenocarcinoma | 26 | N/A* | N/A* |
COADREAD§ | Colorectal adenocarcinoma | 32 | N/A* | N/A* |
HNSC | Head and neck squamous cell carcinoma | 43 | 477 | 60.6 |
KICH | Kidney chromophobe | 25 | N/A* | N/A* |
KIPAN§ | Pan-kidney cohort (KICH + KIRC + KIRP) | 129 | 759 | 74.8 |
KIRC | Kidney renal clear cell carcinoma | 72 | 461 | 67.9 |
KIRP | Kidney renal papillary cell carcinoma | 32 | 257 | 85.6 |
LIHC | Liver hepatocellular carcinoma | 50 | 320 | 70.0 |
LUAD | Lung adenocarcinoma | 58 | 449 | 65.0 |
LUSC | Lung squamous cell carcinoma | 51 | 444 | 59.5 |
PRAD | Prostate adenocarcinoma | 52 | 445 | 97.8 |
THCA | Thyroid carcinoma | 59 | 442 | 97.3 |